Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (26)
  • 2024 (19)
  • 2023 (14)
  • 2022 (20)
  • 2021 (42)
  • 2020 (38)
  • 2019 (37)
  • 2018 (40)
  • 2017 (35)
  • 2016 (22)
  • 2015 (15)
  • 2014 (22)
  • 2013 (39)
  • 2012 (8)
  • 2011 (32)

Subject

  • Diversion Division (1)
  • Prescription Drugs (1)

Field Division

  • New England (174)
  • Houston (84)
  • New York (84)
  • Miami (62)
  • New Orleans (60)
  • San Francisco (60)
  • Atlanta (54)
  • Seattle (46)
  • Detroit (43)
  • St. Louis (41)
  • Chicago (35)
  • Washington, DC (27)
  • Los Angeles (26)
  • New Jersey (24)
  • El Paso (19)
  • Philadelphia (19)
  • Caribbean (14)
  • Dallas (14)
  • Phoenix (13)
  • Rocky Mountain (13)
  • San Diego (12)
  • Louisville (1)
  • Omaha (1)
  • Headquarters (16)
Clear All Results
16 Results - Showing 1 to 10
PRESS RELEASE

DEA Releases 2026 Aggregate Production Quotas

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...
PRESS RELEASE

DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

WASHINGTON - The United States Drug Enforcement (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances (CSA) for those who are conducting FDA-approved clinical trials on (CBD), an extract of the marijuana plant. These modifications will streamline the research process regarding CBD’s possible medicinal value and...
PRESS RELEASE

DEA Announces “360 Strategy” To Address Heroin, Prescription Drugs And Violent Crime

PITTSBURGH - The United States Drug Enforcement Administration today announced Pittsburgh as the pilot city for a comprehensive law enforcement and prevention “360 Strategy” to help cities dealing with a heroin and prescription drug abuse epidemic, and its associated violent crime. DEA Special Agent in Charge for the Philadelphia Division...
PRESS RELEASE

DEA Releases 2015 Drug Threat Assessment: Heroin And Painkiller Abuse Continue To Concern

WASHINGTON - DEA Acting Administrator Chuck Rosenberg today announced results from the 2015 National Drug Threat (NDTA), which found that drug overdose deaths are the leading cause of injury death in the United States, ahead of deaths from motor vehicle accidents and firearms. In 2013, more than 46,000 people in...
PRESS RELEASE

151 Arrested In DEA-Led Investigation Of Synthetic Drug Rings

WASHINGTON - The Drug Enforcement (DEA), Immigration and Customs (ICE) Homeland Security (HSI), Customs and Border (CBP), along with other federal, state, and local law enforcement today concluded a 15-month, nationwide drug interdiction effort that resulted in 151 arrests in 16 states. The enforcement action, known as Project Synergy III...
PRESS RELEASE

DEA’S Prescription Drug Take-Back Effort-- A Big Success

WASHINGTON - Thousands of Americans in communities across the country discarded more than 350 tons of unused, expired, or unwanted drugs as part of the Drug Enforcement Administration’(DEA) National Prescription Drug Take-Back Day (NTBI) on Saturday, September 26. This past weekend, more than 3,800 federal, state and local counterparts took...
PRESS RELEASE

DEA Dialogues With Registrants On Preventing Pharmaceutical Diversion At Conference This Week

WASHINGTON - The new head of the U.S. Drug Enforcement Administration’(DEA’s) Office of Diversion Control met with the agency’s registered pharmaceutical manufacturers, importers, and exporters this week to discuss how they can prevent pharmaceutical diversion while minimizing the impact on legitimate commerce. Almost 300 registrants attended the conference held September...
PRESS RELEASE

DEA Announces Major Steroid Operation

(WASHINGTON - DEA officials today announced a nationwide series of enforcement actions targeting every level of the global underground trade of anabolic steroids and other performance-enhancing drugs, the vast majority of which are manufactured and trafficked from underground labs in China. DEA-led Operation Cyber Juice comprised of over 30 different...
PRESS RELEASE

DEA Announces Tip Line, Wanted Poster For Chapo

WASHINGTON, D.C. - The Drug Enforcement (DEA) announced today a toll-free tip line where the general public in the United States, Mexico, Central and South America can report any information that could aid in the apprehension of Sinaloa Cartel leader Joaquin “El Chapo” Guzman-Loera, who escaped a Mexican prison in...
PRESS RELEASE

DEA Announces 10th National Prescription Drug Take-Back

WASHINGTON - DEA Acting Administrator Chuck Rosenberg today announced that the 10th National Prescription Drug Take-Back will take place September 26th from 10 am-2 pm local time in every state but Pennsylvania and Delaware, where the event will take place on September 12. As with the previous nine Take-Back events...

Pagination

  • Current page 1
  • Page 2
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster